A Phase 1 Study of Oral LY3410738 in Patients with Advanced Hematologic Malignancies with IDH1 or IDH2 Mutations.

  • Wei, Andrew (Chief Investigator (CI))
  • Kennedy, Nola (Project Manager)
  • Bajel, Ashish (Chief Investigator (CI))
  • Flemming, Shaun (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date2/12/20 → 31/12/25

Keywords

  • Malignant Haematology
  • Clinical trial